BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gratwohl A, Baldomero H, Passweg J. Hematopoietic stem cell transplantation activity in Europe: . Current Opinion in Hematology 2013;20:485-93. [DOI: 10.1097/moh.0b013e328364f573] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Gaballa A, Arruda LCM, Uhlin M. Gamma delta T-cell reconstitution after allogeneic HCT: A platform for cell therapy. Front Immunol 2022;13:971709. [DOI: 10.3389/fimmu.2022.971709] [Reference Citation Analysis]
2 Kriegsmann K, Pavel P, Bochtler T, Schmitt A, Sauer S, Kriegsmann M, Bruckner T, Klein S, Klüter H, Müller-Tidow C, Wuchter P. Cryostorage to What End? - Autologous Stem Cell Products in Burkitt Lymphoma, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and Myeloproliferative Neoplasm Patients. Transfus Med Hemother 2021;48:91-8. [PMID: 33976609 DOI: 10.1159/000509945] [Reference Citation Analysis]
3 Sauer S, Pavel P, Schmitt A, Cremer M, Kriegsmann M, Bruckner T, Jordan K, Wuchter P, Müller-Tidow C, Kriegsmann K. Low-dose peripheral blood stem cell graft after high-dose chemotherapy - an evaluation of hematopoietic reconstitution. BMC Cancer 2020;20:353. [PMID: 32334570 DOI: 10.1186/s12885-020-06873-7] [Reference Citation Analysis]
4 Maryanovich M, Takeishi S, Frenette PS. Neural Regulation of Bone and Bone Marrow. Cold Spring Harb Perspect Med 2018;8:a031344. [PMID: 29500307 DOI: 10.1101/cshperspect.a031344] [Cited by in Crossref: 20] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
5 Jia H, Cui J, Jia X, Zhao J, Feng Y, Zhao P, Zang D, Yu J, Zhao T, Wang H, Xu K. Therapeutic effects of STAT3 inhibition by nifuroxazide on murine acute graft graft-vs.-host disease: Old drug, new use. Mol Med Rep 2017;16:9480-6. [PMID: 29152660 DOI: 10.3892/mmr.2017.7825] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
6 Jia H, Zhao T, Ji Y, Jia X, Ren W, Li C, Li M, Xiao Y, Wang H, Xu K. Combined nifuroxazide and SAT05f therapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation. Cell Death Dis 2016;7:e2507. [PMID: 27906171 DOI: 10.1038/cddis.2016.399] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
7 Espigado I, Ortega-Ortega M, Montero-Granados R, Rodriguez-Torres N, Márquez-Malaver FJ. Differences in stem cell transplantation activity among regions in Spain: an economic explanation. Bone Marrow Transplant 2016;51:1537-9. [PMID: 27376450 DOI: 10.1038/bmt.2016.177] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
8 Hanoun M, Maryanovich M, Arnal-Estapé A, Frenette PS. Neural regulation of hematopoiesis, inflammation, and cancer. Neuron 2015;86:360-73. [PMID: 25905810 DOI: 10.1016/j.neuron.2015.01.026] [Cited by in Crossref: 121] [Cited by in F6Publishing: 133] [Article Influence: 17.3] [Reference Citation Analysis]
9 Yuan J, Ren HY, Shi YJ, Liu W. Prophylaxis of acute graft-versus-host disease by CCR5 blockade combined with cyclosporine A in a murine model. Inflamm Res 2015;64:137-44. [PMID: 25556580 DOI: 10.1007/s00011-014-0793-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
10 Martino M, Lanza F, Demirer T, Moscato T, Secondino S, Pedrazzoli P; European Society for Blood and Marrow Transplantation, Solid Tumors Working Party (EBMT-STWP). Erythropoiesis-stimulating agents in allogeneic and autologous hematopoietic stem cell transplantation. Expert Opin Biol Ther 2015;15:195-211. [PMID: 25315815 DOI: 10.1517/14712598.2015.971749] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]